ARALEZ PHARMACEUTICALS INC. Retained Earnings
ARALEZ PHARMACEUTICALS INC. had Retained Earnings of -$382.63 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-05-08
- 2018-03-31: Retained Earnings (Accumulated Deficit) -$382.63M.
- 2017-12-31: Retained Earnings (Accumulated Deficit) -$362.87M.
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$317.10M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$292.66M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2018-03-31 | -$382.63M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$362.87M 10-Q · filed 2018-05-08 |
| 2017-09-30 | -$317.10M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$292.66M 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$265.14M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$237.67M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$206.55M 10-Q · filed 2016-11-08 |
| 2016-06-30 | -$185.95M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$168.48M 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$134.69M 10-K · filed 2017-03-13 |